Genzyme Corporation remains in dispute with Impax Laboratories, Inc. over U.S. Patent No. 5,667,775, which expires in 2014.
The Company received notice in 2009, from Impax that it had submitted to…
Lupin Ltd. and Lupin Pharmaceuticals continue to challenge Genzyme Corporation’s U.S. Patent No. 5,667,775, which expires in 2014.
The Company received notice in 2009 from Lupin that it had submitted to…
Genzyme Corporation is pursuing a Hectorol patent infringement action against Roxane Laboratories, Inc., in the U.S. District Court for the District of Delaware.
On July 31, 2009, the company filed a…
Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.
Beginning in January 2009, the company received notices from…
Genzyme Corporation is pursuing an amended patent infringement complaint against Pentech Pharmaceuticals, Inc.
In January 2008, the company received notice that Pentech had submitted to the U.S. Food and Drug Administration…
Genzyme Corporation’s patent infringement suit against Eagle Pharmaceuticals, Inc., remains pending in the U.S. District Court for the District of Delaware.
In March 2009, the company received notice that Eagle had…
Genzyme Corporation is engaged in dispute with Sandoz, Inc., over infringement of the Renagel patent.
The company on July 2, 2009, filed a complaint against Sandoz in the U.S. District Court…
Genzyme Corporation and its wholly owned subsidiary Bone Care International, LLC, pursue a Hectorol patent infringement complaint against Sandoz Inc.
In June 2009, the company received notice that Sandoz had submitted…
Genzyme Corp. is in a dispute with Abbott Laboratories over the percentage of infringing product that was supplied by the Company.
The Company said that it may in the future…